T. Todd Morrill
Orinda, CA ***63
****.*******@*****.***
Experienced C-suite bio/pharma and life sciences executive who has built and led organizations as CEO, Chief Business Officer and General Manager. Experienced at startups, midsize 25- 350 person companies/divisions. In Fortune 500 companies, Senior Vice President of Corporate Development, and embedded restructuring/spinout (consulting) VP. I have spent half my career in VC-backed startups, and the other half in large organizations. I am currently a consultant to federal research agencies (NSF, DOE, NIH) and Fortune Global 1000 companies, and am an advisor to several startups. 2011 – current CEO, Venture Merchant Group
Consult with corporate and large organizations in innovation culture and practice. Clients include Mayo Clinic, UCSF, World Bank Group, Caterpillar Corporation, WL Gore, LG Corp, and many federal research agencies. Coached more than 1200 teams developing science and technology-based products and technologies. Built internal innovation teams, launched new product Divisions and successfully financed many (hundreds) from internal and external sources.
2003 – 2011 Senior Vice President, Corporate Development, Bio-Rad Laboratories Responsible for sourcing, negotiating and closing major M&A transactions. Led strategic initiatives (including >$100M acquisitions) to establish Bio-Rad as a market leader in PCR technologies, then again in digital droplet PCR. Grew total corporate revenues by 30% via acquisition, and sourced the new technologies which have grown into a $5B division. Consolidated service and technology competitors and partners via acquisition to build a market- leading IVD blood-typing division.
Managed a portfolio of internal and external innovation projects. Invested an evergreen fund of
$8M. Developed and managed the strategic planning process for this $12B diagnostics and research product company. Reported to CEO, and to President of Life Sciences Group. Completed 17 major M&A transactions and over 50 licensing deals. Sourced and negotiated transactions, managed post-acquisition integration. Teams varied from 3 to 30+ depending on the transaction. Represented both strategy and specific transactions to the Board of Directors. 2002 – 2003 CEO and Chairman, IO Informatics, Inc. Restructured and refinanced this 20-person software company over 20 months. Negotiated and discharged more than $4M in debt, raised $2.1M in new capital, searched for and found a software CEO. Launched the first product.
2001 – 2002 Chief Business Officer, Trellis Bioscience Raised $7.5M in venture capital for drug discovery instrumentation and assays. Helped develop the lead (pharmaceutical) product. Managed day to day operations and commercial strategy for 25 staff scientists and engineers.
1995 – 2001 Managing Partner, Burrill & Company
Managed the strategic partnering and M&A business for this SF-based investment bank. Spun out research divisions and drug portfolios from large pharmaceutical companies. Completed more than 20 transactions on behalf of Pfizer, Eli Lilly, Baxter Labs, Schering and many small biotech firms.
1983 – 1995
Started in R&D at Bio-Rad Labs and moved a variety of roles in marketing, sales and business development. Founder of Novex, Inc (sold to Invitrogen/Fisher). Second employee at Oxford Glycosciences (sold to Celltech).
Education
Haas School of Business, UC Berkeley, MBA
Dartmouth College, Biology, AB with Highest Honors